🔎 Trials Near Me

Home › Obesità › California

Studi clinici su Obesità nello stato di California

99 studi su Obesità cercano partecipanti presso sedi nello stato di California.

Città nello stato di California

Testo ufficiale dello studio (inglese)

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

  • John Muir Health - Concord /ID# 282469, Concord
  • NorCal Medical Research /ID# 283117, Greenbrae
  • Velocity Clinical Research - Huntington Park /ID# 282987, Huntington Park
  • e altri 6
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT07752979

Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population

  • San Diego State University, San Diego
In reclutamentoVolontari sani benvenuti
Età da 18 a 64 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05279729

Efficacy of Using Mobile Health Applications for Health

  • San Diego State University, San Diego
In reclutamentoVolontari sani benvenuti
Età da 18 a 64 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05589155

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects

  • ProSciento, INC, Chula Vista
In reclutamentoFase 1Volontari sani benvenuti
Età da 18 a 70 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT07675590

Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients

  • Cedars Sinai Medical Center, Los Angeles
In reclutamento
Età da 21 a 65 · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT07090005

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Thrive Clinical Research Group, Glendora
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07783802

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

  • Torrance Clinical Research Institute, Inc., Lomita
  • Diablo Clinical Research, Inc., Walnut Creek
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07533175

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

  • Neighborhood Healthcare, Escondido
In reclutamentoFase 3
Età da 8 a 18 · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07253285

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

  • Diablo Clinical Research - Flourish Research, Walnut Creek
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 set 2026 · NCT07685808

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

  • Profound Research, Oceanside
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07837973

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

  • Providence Medical Foundation, Fullerton
  • Torrance Clinical Research Institute, Inc., Lomita
  • Diablo Clinical Research, Inc., Walnut Creek
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07720271

Stanford Healthy Goals Study

  • Stanford University, Stanford
In reclutamento
Età da 10 a 15 · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07839832

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

  • First Valley Medical Group, Lancaster
  • Desert Oasis Healthcare, Palm Springs
  • Western University of Health Sciences, Pomona
  • e altri 1
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07668414

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  • San Fernando Valley Health Institute, Canoga Park
  • Headlands Research California, LLC, Escondido
  • ImmuniMet, LLC, Modesto
  • e altri 4
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07595549

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

  • Research Site, Escondido
  • Research Site, Lincoln
  • Research Site, Walnut Creek
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07776509

Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity

  • Parexel International, Glendale
In reclutamentoFase 1Volontari sani benvenuti
Età da 18 a 65 · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07594093

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  • Smart Cures Clinical Research, Anaheim
  • Cedars-Sinai Medical Center, Beverly Hills
  • United Medical Doctors - Los Alamitos, Los Alamitos
  • e altri 1
In reclutamentoFase 3
Età da 18 a 70 · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  • Loma Linda University School of Medicine, Loma Linda
  • Childrens Hospital of Los Angeles, Los Angeles
  • UCLA Mattel Children's Hospital, Los Angeles
  • e altri 2
In reclutamentoFase 3
Età da 6 a 17 · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Smart Cures Clinical Research, Anaheim
  • Cedars-Sinai Medical Center, Beverly Hills
  • United Medical Doctors - Los Alamitos, Los Alamitos
  • e altri 1
In reclutamentoFase 3
Età da 18 a 70 · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06937086

A Study to Learn How Different Amounts of the Study Medicine Called PF-08642534 Are Tolerated and Act in the Body of People Who Have Obesity

  • Orange County Research Center, Lake Forest
In reclutamentoFase 1
Età da 18 a 70 · Tutti i sessi · Aggiornato il 23 set 2026 · NCT07731139

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • San Fernando Valley Health Institute, Canoga Park
  • AMCR Institute, Escondido
  • NorCal Medical Research, Inc, Greenbrae
  • e altri 6
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

  • Irvine Clinical Research, Irvine
  • Scripps Whittier Diabetes Institute, La Jolla
  • EndoTrials Center for Clinical Research, La Mesa
  • e altri 5
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Bakersfield
  • Research Site, Gardena
  • Research Site, Lincoln
  • e altri 2
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07784270

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

  • Ark Clinical Research, Long Beach
  • Collaborative Neuroscience Research, LLC, Los Alamitos
  • Artemis Institute for Clinical Research, Riverside
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07369011

CHOICE to AVOID or RESIST

  • Cedars-Sinai Medical Center, Beverly Hills
In reclutamentoVolontari sani benvenuti
Età da 18 a 80 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06521021

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Valley Clinical Trials, LLC dba Flourish Research, Covina
  • Velocity Clinical Research- Huntington Park, Huntington Park
  • Orange County Research Center, Lake Forest
  • e altri 5
In reclutamentoFase 3
Età da 45 a 99 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

  • Neighborhood Healthcare Institute of Health, Escondido
  • Ark Clinical Research - Fountain Valley, Fountain Valley
  • Desert Oasis Healthcare Medical Group, Palm Springs
  • e altri 4
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07321886

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

  • Ark Clinical Research - Fountain Valley, Fountain Valley
  • Wolverine Clinical Trials, Santa Ana
  • Encompass Clinical Research, Spring Valley
  • e altri 1
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

  • NorCal Medical Research, Inc, Greenbrae
  • Velocity Clinical Research, Huntington Park, Huntington Park
  • Peninsula Research Associates, Rolling Hills Estates
  • e altri 1
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

  • AURORA-1 Clinical Site, Banning
  • AURORA-1 Clinical Site, Chula Vista
  • AURORA-1 Clinical Site, Covina
  • e altri 5
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 set 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Banning
  • AURORA-2 Clinical Site, Chula Vista
  • AURORA-2 Clinical Site, Covina
  • e altri 6
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 set 2026 · NCT07743450

A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants

  • Research Site, Glendale
In reclutamentoFase 1Volontari sani benvenuti
Età da 18 a 55 · Tutti i sessi · Aggiornato il 16 set 2026 · NCT07723833

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • National Heart Institute, Beverly Hills
  • Valley Clinical Trials, LLC dba Flourish Research, Covina
  • National Institute of Clinical Research, Huntington Beach
  • e altri 9
In reclutamentoFase 3
Età da 18 a 99 · Tutti i sessi · Aggiornato il 16 set 2026 · NCT07037459

An Online Intuitive Eating Program for Pregnant Women With Obesity to Support Well-Being

  • San Diego State University, San Diego
  • UC San Diego Health, San Diego
In reclutamento
Età 18 e oltre · Donne · Aggiornato il 15 set 2026 · NCT07792837

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Orange County Research Center, Lake Forest
  • Ark Clinical Research, Long Beach
  • Catalina Research Institute, LLC, Montclair
  • e altri 3
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 14 set 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

  • Wolverine Clinical Trials, Santa Ana
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 14 set 2026 · NCT06897475

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  • University of California Irvine, Irvine
  • Artemis Institute for Clinical Research, LLC, San Diego
  • Diablo Clinical Research, Inc., Walnut Creek
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 14 set 2026 · NCT07351045

First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671

  • Research Site, Cypress
  • Research Site, Lake Forest
In reclutamentoFase 1/2Volontari sani benvenuti
Età da 25 a 75 · Tutti i sessi · Aggiornato il 14 set 2026 · NCT07815678

Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.